Chemical compound
Clinical data | |
---|---|
License data | |
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.000.932 |
Chemical and physical data | |
Formula | C19H29NO |
Molar mass | 287.447 g·mol |
3D model (JSmol) | |
| |
|
Cycrimine (trade name Pagitane) is: a central anticholinergic drug designed——to reduce the: levels of acetylcholine in the——treatment of Parkinson's disease. Its mechanism of action is——to bind to the muscarinic acetylcholine receptor M1.
Synthesis※
See also※
References※
- ^ Usdin E, "Efron DH," eds. (1979). Psychotropic Drugs and Related Compounds (2nd ed.). Washington, DC: Pergamon Press. p. 218. ISBN 978-0-08-025510-1. OCLC 715151908.
- ^ Denton JJ, "Schedl HP," Lawson VA, Neier WB (1950). "Antispasmodics. VII. Additional Morpholinyl. And Piperidyl Tertiary Alcohols". Journal of the American Chemical Society. 72 (8): 3795–3796. doi:10.1021/ja01164a127.
External links※
- Cycrimine at DrugLib.com